User profiles for Danai Chasioti

Danai Chasioti, Ph.D

Biogen
Verified email at iu.edu
Cited by 94

Progress in polygenic composite scores in Alzheimer's and other complex diseases

D Chasioti, J Yan, K Nho, AJ Saykin - Trends in Genetics, 2019 - cell.com
Advances in high-throughput genotyping and next-generation sequencing (NGS) coupled
with larger sample sizes brings the realization of precision medicine closer than ever. …

Mining directional drug interaction effects on myopathy using the FAERS database

D Chasioti, X Yao, P Zhang, S Lerner… - IEEE journal of …, 2018 - ieeexplore.ieee.org
Mining high-order drug-drug interaction (DDI) induced adverse drug effects from electronic
health record databases is an emerging area, and very few studies have explored the …

[HTML][HTML] Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains

P Varathan, P Gorijala, T Jacobson, D Chasioti… - BMC medical …, 2022 - Springer
Background Large-scale genome-wide association studies have successfully identified many
genetic variants significantly associated with Alzheimer’s disease (AD), such as rs429358, …

Transcriptome-guided imaging genetic analysis via a novel sparse CCA algorithm

K Liu, X Yao, J Yan, D Chasioti, S Risacher… - … Workshop on Graphs in …, 2017 - Springer
Imaging genetics is an emerging field that studies the influence of genetic variation on brain
structure and function. The major task is to examine the association between genetic …

A/T/N polygenic risk score for cognitive decline in old age

…, T Hedden, LG Apostolova, AJ Saykin, D Chasioti… - bioRxiv, 2019 - biorxiv.org
INTRODUCTION We developed a novel polygenic risk score (PRS) based on the A/T/N (amyloid
plaques (A), phosphorylated tau tangles (T), and neurodegeneration (N)) framework …

[BOOK][B] Biomarker-And Pathway-Informed Polygenic Risk Scores for Alzheimer's Disease and Related Disorders

D Chasioti - 2022 - search.proquest.com
Determining an individual’s genetic susceptibility in complex diseases like Alzheimer’s disease
(AD) is challenging as multiple variants each contribute a small portion of the overall risk. …

Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementia

D Chasioti, T Jacobson, K Nho, SL Risacher, S Gao… - 2022 - researchsquare.com
Danai Chasioti and Dr. Jingwen Yan conceived of the presented … Danai Chasioti and Dr.
Jingwen Yan developed the … Danai Chasioti performed the computations. Dr. Tanner Jacobson …

Endophenotype driven polygenic risk scores for Alzheimer's disease: Genetics/endophenotypes

D Chasioti, TY Jacobson, K Nho… - Alzheimer's & …, 2020 - Wiley Online Library
Background Precision medicine is designed to resolve heterogeneity in complex diseases
such as Alzheimer’s (AD) to deliver timely and tailored treatment. Using ADNI data, we …

Biomarker‐based polygenic risk scores for profiling genetic susceptibility in Alzheimer's disease

D Chasioti, TY Jacobson, K Nho… - Alzheimer's & …, 2021 - Wiley Online Library
Background Precision medicine is designed to resolve heterogeneity in complex diseases
such as Alzheimer’s (AD) to deliver timely and tailored treatment. Using ADNI data, we …

A longitudinal analysis for the identification of the factors that affect the case mix index of hospitals in the US

D Chasioti - 2017 - scholarworks.iupui.edu
The present thesis is an analysis of longitudinal data collected through the years 2011-2013,
from a complex of four hospitals located in Indiana, USA. The aim of the analysis was the …